Assistant professor of biomedical engineering at Duke University Charles Gersbach Researchers have gained control of gene activity through the synthetic creation of a key component of the epigenome that controls gene expression. The research was carried out by a group of scientists from the Duke University and published in the online journal Nature Biotechnology on Monday. “The epigenome is everything... 

A new research has demonstrated that drug bazedoxifene packs can cut the growth of breast cancer cells, even in resistant tumors. The findings show that medicines prescribed for osteoporosis cut growth both in estrogen-dependent breast cancer cells and in cells that had developed resistance to current targeted therapies, according to a Duke Cancer Institute study. “We found bazedoxifene binds...